1.1 List of Tables
Table 1: In Vitro Diagnostics Market, Germany, Revenue ($m), USD Constant, 2015-2025 49
Table 2: In Vitro Diagnostics Market, Germany, Category Contribution by Revenue ($m), 2018 52
Table 3: In Vitro Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2015-2020 54
Table 4: In Vitro Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2021-2025 55
Table 5: In Vitro Diagnostics Market, Germany, Volume (Units), 2015-2025 57
Table 6: In Vitro Diagnostics Market, Germany, Volume (Units), Historic, 2015-2020 59
Table 7: In Vitro Diagnostics Market, Germany, Volume (Units), Forecast, 2021-2025 60
Table 8: In Vitro Diagnostics Market, Germany, Company Share by Revenue ($m), USD Constant, 2018 62
Table 9: Cardiac Disease Market, Germany, Revenue ($m), USD Constant, 2015-2020 64
Table 10: Cardiac Disease Market, Germany, Revenue ($m), USD Constant, 2021-2025 64
Table 11: Cardiac Marker Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 66
Table 12: Cardiac Marker Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 67
Table 13: Cardiac Disease Market, Germany, Volume (Units), 2015-2020 69
Table 14: Cardiac Disease Market, Germany, Volume (Units), 2021-2025 69
Table 15: Cardiac Marker Tests Market, Germany, Volume (Units), 2015-2020 71
Table 16: Cardiac Marker Tests Market, Germany, Volume (Units), 2021-2025 72
Table 17: Cardiac Disease Market, Germany, Average Price ($), 2015-2020 73
Table 18: Cardiac Disease Market, Germany, Average Price ($), 2021-2025 74
Table 19: Cardiac Disease Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2018 75
Table 20: Cardiac Disease Market, Germany, Company Share by Revenue ($m), USD Constant, 2018 77
Table 21: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, 2015-2020 79
Table 22: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, 2021-2025 79
Table 23: Substrates Market, Germany, Revenue ($m), USD Constant, 2015-2020 81
Table 24: Substrates Market, Germany, Revenue ($m), USD Constant, 2021-2025 82
Table 25: Clinical Chemistry Market, Germany, Volume (Units), 2015-2020 84
Table 26: Clinical Chemistry Market, Germany, Volume (Units), 2021-2025 84
Table 27: Substrates Market, Germany, Volume (Units), 2015-2020 86
Table 28: Substrates Market, Germany, Volume (Units), 2021-2025 87
Table 29: Clinical Chemistry Market, Germany, Average Price ($), 2015-2020 88
Table 30: Clinical Chemistry Market, Germany, Average Price ($), 2021-2025 89
Table 31: Clinical Chemistry Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2018 90
Table 32: Clinical Chemistry Market, Germany, Company Share by Revenue ($m), USD Constant, 2018 91
Table 33: Hematological Disorders Market, Germany, Segment Contribution (%), 2018 93
Table 34: Hematological Disorders Market, Germany, Revenue ($m), USD Constant, 2015-2020 95
Table 35: Hematological Disorders Market, Germany, Revenue ($m), USD Constant, 2021-2025 95
Table 36: Hematology Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 97
Table 37: Hematology Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 98
Table 38: Hemostasis Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 100
Table 39: Hemostasis Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 101
Table 40: Hematological Disorders Market, Germany, Volume (Units), 2015-2020 103
Table 41: Hematological Disorders Market, Germany, Volume (Units), 2021-2025 103
Table 42: Hematology Tests Market, Germany, Volume (Units), 2015-2020 105
Table 43: Hematology Tests Market, Germany, Volume (Units), 2021-2025 106
Table 44: Hemostasis Tests Market, Germany, Volume (Units), 2015-2020 108
Table 45: Hemostasis Tests Market, Germany, Volume (Units), 2021-2025 109
Table 46: Hematological Disorders Market, Germany, Average Price ($), 2015-2020 110
Table 47: Hematological Disorders Market, Germany, Average Price ($), 2021-2025 112
Table 48: Hematological Disorders Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2018 114
Table 49: Hematological Disorders Market, Germany, Company Share by Revenue ($m), USD Constant, 2018 116
Table 50: Hormonal Disorders Market, Germany, Revenue ($m), USD Constant, 2015-2020 118
Table 51: Hormonal Disorders Market, Germany, Revenue ($m), USD Constant, 2021-2025 118
Table 52: Thyroid Function Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 120
Table 53: Thyroid Function Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 121
Table 54: Hormonal Disorders Market, Germany, Volume (Units), 2015-2020 123
Table 55: Hormonal Disorders Market, Germany, Volume (Units), 2021-2025 123
Table 56: Thyroid Function Tests Market, Germany, Volume (Units), 2015-2020 125
Table 57: Thyroid Function Tests Market, Germany, Volume (Units), 2021-2025 126
Table 58: Hormonal Disorders Market, Germany, Average Price ($), 2015-2020 127
Table 59: Hormonal Disorders Market, Germany, Average Price ($), 2021-2025 128
Table 60: Hormonal Disorders Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2018 129
Table 61: Hormonal Disorders Market, Germany, Company Share by Revenue ($m), USD Constant, 2018 131
Table 62: Infectious Disease Market, Germany, Segment Contribution (%), 2018 134
Table 63: Infectious Disease Market, Germany, Revenue ($m), USD Constant, 2015-2020 136
Table 64: Infectious Disease Market, Germany, Revenue ($m), USD Constant, 2021-2025 137
Table 65: Chlamydia Trachomatis Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 139
Table 66: Chlamydia Trachomatis Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 139
Table 67: Clostridium difficile Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 141
Table 68: Clostridium difficile Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 142
Table 69: Cytomegalovirus (CMV) Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 144
Table 70: Cytomegalovirus (CMV) Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 144
Table 71: Hepatitis Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 146
Table 72: Hepatitis Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 146
Table 73: Human Immunodeficiency Virus (HIV) Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 148
Table 74: Human Immunodeficiency Virus (HIV) Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 149
Table 75: Human Papilloma Virus (HPV) Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 151
Table 76: Human Papilloma Virus (HPV) Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 151
Table 77: Human T-Lymphotropic Virus (HTLV) Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 153
Table 78: Human T-Lymphotropic Virus (HTLV) Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 153
Table 79: Mycobacterium Tuberculosis Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 155
Table 80: Mycobacterium Tuberculosis Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 155
Table 81: Neisseria Gonorrhoeae Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 157
Table 82: Neisseria Gonorrhoeae Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 157
Table 83: Treponema pallidum Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 159
Table 84: Treponema pallidum Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 160
Table 85: Infectious Disease Market, Germany, Volume (Units), 2015-2020 162
Table 86: Infectious Disease Market, Germany, Volume (Units), 2021-2025 164
Table 87: Chlamydia Trachomatis Tests Market, Germany, Volume (Units), 2015-2020 167
Table 88: Chlamydia Trachomatis Tests Market, Germany, Volume (Units), 2021-2025 167
Table 89: Clostridium difficile Tests Market, Germany, Volume (Units), 2015-2020 169
Table 90: Clostridium difficile Tests Market, Germany, Volume (Units), 2021-2025 170
Table 91: Cytomegalovirus (CMV) Tests Market, Germany, Volume (Units), 2015-2020 172
Table 92: Cytomegalovirus (CMV) Tests Market, Germany, Volume (Units), 2021-2025 172
Table 93: Hepatitis Tests Market, Germany, Volume (Units), 2015-2020 174
Table 94: Hepatitis Tests Market, Germany, Volume (Units), 2021-2025 174
Table 95: Human Immunodeficiency Virus (HIV) Tests Market, Germany, Volume (Units), 2015-2020 176
Table 96: Human Immunodeficiency Virus (HIV) Tests Market, Germany, Volume (Units), 2021-2025 177
Table 97: Human Papilloma Virus (HPV) Tests Market, Germany, Volume (Units), 2015-2020 179
Table 98: Human Papilloma Virus (HPV) Tests Market, Germany, Volume (Units), 2021-2025 179
Table 99: Human T-Lymphotropic Virus (HTLV) Tests Market, Germany, Volume (Units), 2015-2020 181
Table 100: Human T-Lymphotropic Virus (HTLV) Tests Market, Germany, Volume (Units), 2021-2025 181
Table 101: Mycobacterium Tuberculosis Tests Market, Germany, Volume (Units), 2015-2020 183
Table 102: Mycobacterium Tuberculosis Tests Market, Germany, Volume (Units), 2021-2025 183
Table 103: Neisseria Gonorrhoeae Tests Market, Germany, Volume (Units), 2015-2020 185
Table 104: Neisseria Gonorrhoeae Tests Market, Germany, Volume (Units), 2021-2025 185
Table 105: Treponema pallidum Tests Market, Germany, Volume (Units), 2015-2020 187
Table 106: Treponema pallidum Tests Market, Germany, Volume (Units), 2021-2025 188
Table 107: Infectious Disease Market, Germany, Average Price ($), 2015-2020 189
Table 108: Infectious Disease Market, Germany, Average Price ($), 2021-2025 192
Table 109: Infectious Disease Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2018 195
Table 110: Infectious Disease Market, Germany, Company Share by Revenue ($m), USD Constant, 2018 197
Table 111: IVD Analyzers and Reagents Market, Germany, Segment Contribution (%), 2018 199
Table 112: IVD Analyzers and Reagents Market, Germany, Revenue ($m), USD Constant, 2015-2020 201
Table 113: IVD Analyzers and Reagents Market, Germany, Revenue ($m), USD Constant, 2021-2025 202
Table 114: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, 2015-2020 204
Table 115: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, 2021-2025 204
Table 116: Hematology Analyzers Market, Germany, Revenue ($m), USD Constant, 2015-2020 206
Table 117: Hematology Analyzers Market, Germany, Revenue ($m), USD Constant, 2021-2025 207
Table 118: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, 2015-2020 209
Table 119: Immunochemistry Analyzers Market, Germany, Revenue ($m), USD Constant, 2021-2025 210
Table 120: Polymerase Chain Reaction (PCR) Systems Market, Germany, Revenue ($m), USD Constant, 2015-2020 212
Table 121: Polymerase Chain Reaction (PCR) Systems Market, Germany, Revenue ($m), USD Constant, 2021-2025 213
Table 122: IVD Analyzers and Reagents Market, Germany, Volume (Units), 2015-2020 215
Table 123: IVD Analyzers and Reagents Market, Germany, Volume (Units), 2021-2025 216
Table 124: Clinical Chemistry Analyzers Market, Germany, Volume (Units), 2015-2020 218
Table 125: Clinical Chemistry Analyzers Market, Germany, Volume (Units), 2021-2025 218
Table 126: Hematology Analyzers Market, Germany, Volume (Units), 2015-2020 220
Table 127: Hematology Analyzers Market, Germany, Volume (Units), 2021-2025 221
Table 128: Immunochemistry Analyzers Market, Germany, Volume (Units), 2015-2020 223
Table 129: Immunochemistry Analyzers Market, Germany, Volume (Units), 2021-2025 224
Table 130: Polymerase Chain Reaction (PCR) Systems Market, Germany, Volume (Units), 2015-2020 226
Table 131: Polymerase Chain Reaction (PCR) Systems Market, Germany, Volume (Units), 2021-2025 227
Table 132: IVD Analyzers and Reagents Market, Germany, Average Price ($), 2015-2020 228
Table 133: IVD Analyzers and Reagents Market, Germany, Average Price ($), 2021-2025 230
Table 134: IVD Analyzers and Reagents Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2018 232
Table 135: IVD Analyzers and Reagents Market, Germany, Company Share by Revenue ($m), USD Constant, 2018 234
Table 136: Metabolic Disorder Market, Germany, Revenue ($m), USD Constant, 2015-2020 236
Table 137: Metabolic Disorder Market, Germany, Revenue ($m), USD Constant, 2021-2025 236
Table 138: Diabetes Assays Market, Germany, Revenue ($m), USD Constant, 2015-2020 238
Table 139: Diabetes Assays Market, Germany, Revenue ($m), USD Constant, 2021-2025 239
Table 140: Metabolic Disorder Market, Germany, Volume (Units), 2015-2020 241
Table 141: Metabolic Disorder Market, Germany, Volume (Units), 2021-2025 241
Table 142: Diabetes Assays Market, Germany, Volume (Units), 2015-2020 243
Table 143: Diabetes Assays Market, Germany, Volume (Units), 2021-2025 244
Table 144: Metabolic Disorder Market, Germany, Average Price ($), 2015-2020 245
Table 145: Metabolic Disorder Market, Germany, Average Price ($), 2021-2025 246
Table 146: Metabolic Disorder Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2018 247
Table 147: Metabolic Disorder Market, Germany, Company Share by Revenue ($m), USD Constant, 2018 249
Table 148: Oncology Market, Germany, Segment Contribution (%), 2018 252
Table 149: Oncology Market, Germany, Revenue ($m), USD Constant, 2015-2020 254
Table 150: Oncology Market, Germany, Revenue ($m), USD Constant, 2021-2025 255
Table 151: ALK Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 257
Table 152: ALK Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 257
Table 153: BRCA Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 259
Table 154: BRCA Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 259
Table 155: Colorectal Cancer Screening Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 261
Table 156: Colorectal Cancer Screening Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 261
Table 157: EGFR Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 263
Table 158: EGFR Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 264
Table 159: HER2 Amplification Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 266
Table 160: HER2 Amplification Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 266
Table 161: KRAS Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 268
Table 162: KRAS Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 268
Table 163: Oncology Market, Germany, Volume (Units), 2015-2020 270
Table 164: Oncology Market, Germany, Volume (Units), 2021-2025 271
Table 165: ALK Tests Market, Germany, Volume (Units), 2015-2020 273
Table 166: ALK Tests Market, Germany, Volume (Units), 2021-2025 273
Table 167: BRCA Tests Market, Germany, Volume (Units), 2015-2020 275
Table 168: BRCA Tests Market, Germany, Volume (Units), 2021-2025 275
Table 169: Colorectal Cancer Screening Tests Market, Germany, Volume (Units), 2015-2020 277
Table 170: Colorectal Cancer Screening Tests Market, Germany, Volume (Units), 2021-2025 277
Table 171: EGFR Tests Market, Germany, Volume (Units), 2015-2020 279
Table 172: EGFR Tests Market, Germany, Volume (Units), 2021-2025 280
Table 173: HER2 Amplification Tests Market, Germany, Volume (Units), 2015-2020 282
Table 174: HER2 Amplification Tests Market, Germany, Volume (Units), 2021-2025 282
Table 175: KRAS Tests Market, Germany, Volume (Units), 2015-2020 284
Table 176: KRAS Tests Market, Germany, Volume (Units), 2021-2025 284
Table 177: Oncology Market, Germany, Average Price ($), 2015-2020 285
Table 178: Oncology Market, Germany, Average Price ($), 2021-2025 287
Table 179: Oncology Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2018 289
Table 180: Oncology Market, Germany, Company Share by Revenue ($m), USD Constant, 2018 291
Table 181: Women's Health Market, Germany, Segment Contribution (%), 2018 293
Table 182: Women's Health Market, Germany, Revenue ($m), USD Constant, 2015-2020 295
Table 183: Women's Health Market, Germany, Revenue ($m), USD Constant, 2021-2025 295
Table 184: Prenatal Screening Market, Germany, Revenue ($m), USD Constant, 2015-2020 297
Table 185: Prenatal Screening Market, Germany, Revenue ($m), USD Constant, 2021-2025 298
Table 186: Reproductive Hormones and Proteins Tests Market, Germany, Revenue ($m), USD Constant, 2015-2020 300
Table 187: Reproductive Hormones and Proteins Tests Market, Germany, Revenue ($m), USD Constant, 2021-2025 301
Table 188: Women's Health Market, Germany, Volume (Units), 2015-2020 303
Table 189: Women's Health Market, Germany, Volume (Units), 2021-2025 303
Table 190: Prenatal Screening Market, Germany, Volume (Units), 2015-2020 305
Table 191: Prenatal Screening Market, Germany, Volume (Units), 2021-2025 306
Table 192: Reproductive Hormones and Proteins Tests Market, Germany, Volume (Units), 2015-2020 308
Table 193: Reproductive Hormones and Proteins Tests Market, Germany, Volume (Units), 2021-2025 309
Table 194: Women's Health Market, Germany, Average Price ($), 2015-2020 310
Table 195: Women's Health Market, Germany, Average Price ($), 2021-2025 312
Table 196: Women's Health Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2018 314
Table 197: Women's Health Market, Germany, Company Share by Revenue ($m), USD Constant, 2018 316
Table 198: In Vitro Diagnostics Market Pipeline Products 320
Table 199: Qiagen Withdraws Plan to Sell ItSelf 324
Table 200: Cellink to Acquire Cytena for USD33.6 Million 325
Table 201: Abbott Labs Acquires GLP Systems 327
Table 202: Canopy Biosciences Acquires Zellkraftwerk 329
Table 203: Elekta Acquires Minority Stake in iRT Systems 330
Table 204: Oncimmune Acquires Protagen Diagnostics 331
Table 205: Bayer Raises USD1.1 Billion in Private Placement of 2.375% Bonds Due 2079 333
Table 206: Bayer Raises USD830.7 Million in Private Placement of 3.125% Bonds Due 2079 334
Table 207: Merck Raises USD681.98 Million in First Tranche of Private Placement of 0.005% Bonds Due 2023 335
Table 208: Merck Raises USD681.98 Million in Second Tranche of Private Placement of 0.375% Bonds Due 2027 336
Table 209: Merck Raises USD909.31 Million in Third Tranche of Private Placement of 0.875% Bonds Due 2031 337
Table 210: Merck Raises USD560 Million in Private Placement of 1.625% Bonds Due 2079 338
Table 211: Merck Raises USD1.12 Billion in Private Placement of 2.875% Bonds Due 2079 339
Table 212: Centogene Prices IPO of Shares for USD56 Million 340
Table 213: CO.DON to Raise up to USD26 Million in Rights Offering of Shares 342
Table 214: Epigenomics Raises USD9.2 Million in Rights Offering of Shares 343
Table 215: BioNTech Raises USD150 Million in IPO of American Depositary Shares 345
Table 216: CO.DON Raises USD4.8 Million in Rights Offering of Shares 347
Table 217: OpGen and Curetis to Merge 348
Table 218: Personalis Enters into Agreement With Merck 350
Table 219: Fujirebio Europe Enters into Distribution Agreement with Atila Biosystems 351
Table 220: Galectin Therapeutics Enters into Agreement with Siemens Healthineers 352
Table 221: QuantuMDx and SpeeDx Enter into Agreement with Foundation for Innovative New Diagnostics (FIND) 353
Table 222: Qiagen Enters into Licensing Agreement with University of Bonn 354
Table 223: Qiagen Enters into Licensing Agreement with STRATIFYER Molecular 355
Table 224: Pillar Biosciences Enters into Co-Marketing Agreement with MGI Tech 356
Table 225: Siemens Healthineers Enters into Licensing Agreement with Quanterix 357
Table 226: BioMed X Enters into Research Collaboration with Roche Diagnostics 358
Table 227: Sona Nanotech and Expedeon Enter into Partnership 359
Table 228: Definiens and Targos Enter into Collaboration Agreement 360
Table 229: Dongsung Pharma Enters into Licensing Agreement with Korea Electrotechnology Research Institute 361
Table 230: Velabs Therapeutics Enters into Agreement with Chiome Bioscience 362
Table 231: NanoString Technologies and Leica Biosystem Enter into Co-Marketing Agreement 363
Table 232: Curetis and A. Menarini Diagnostics Enter into Distribution Partnership 364
Table 233: ArchiMed Acquires EUROLyser and EuroLab in Management Buyout 365
Table 234: numares Raises Funds through Financing Round 366
Table 235: Lophius Biosciences Raises USD3.4 Million in Financing Round 367
Table 236: GNA Biosolutions Raises USD13.5 Million in Series C Financing 368
Table 237: Inveox Raises USD18.88 Million in Venture Financing 370
Table 238: BioNTech Raises USD325 Million in Series B Financing 371
Table 239: Spindiag Raises USD4.5 Million in Expanded Series A Financing 373
Table 240: miRdetect Raises Funds through Seed Financing 374
Table 241: InfanDx Raises USD6 Million in Financing 375
Table 242: mediaire Raises Funds through Venture Financing 376
Table 243: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 505